3'-O-Methyladenosine(CAS: 10300-22-8)

3'-O-Methyladenosine (CAS: 10300-22-8) falls under various regulatory guidelines such as GHS (Globally Harmonized System of Classification and Labeling of Chemicals) for classification and labeling, REACH (Registration, Evaluation, Authorization and Restriction of Chemicals) for European manufacturers and importers, and FDA/EPA regulations for biocidal and pharmaceutical uses. It is important to consult the specific regulations and guidelines applicable in your region.

Yes, there are several alternatives to 3'-O-Methyladenosine (CAS: 10300-22-8) in synthesis, including other nucleoside analogs such as 3'-Azido-Ade and 2'-Deoxy-3'-Azido-Ade. Common alternative reagents include methylating agents like dimethyl sulfate (DMS) and other chemical modifications that can be used to produce similar functional groups.

The market for 3'-O-Methyladenosine (CAS: 10300-22-8) is growing due to its applications in RNA interference (RNAi) and gene therapy research. Recent research trends include its use as a therapeutic agent for treating viral infections and certain types of cancer. The demand for this compound is expected to increase as more studies validate its potential in these applications.

Waste containing 3'-O-Methyladenosine (CAS: 10300-22-8) should be collected in appropriate containers and stored securely to prevent spills or leaks. It should be disposed of via incineration or professional waste disposal services that handle hazardous chemicals. Environmental protection precautions include proper labeling and documentation, as well as following local waste disposal regulations and guidelines.